天中依脉品牌怎么样 申请店铺

我要投票 天中依脉在医疗保健行业中的票数:834 更新时间:2025-07-24
公司简介: 天中依脉集团成立于2009年,现拥有三家全资子公司:天津市天中依脉科技开发有限公司、依脉人工智能医疗科技(天津)有限公司和汇汉依脉智能科技(上海)有限公司。公司坐落于天津滨海高新区华苑产业

外推网助力天中依脉品牌出海!将品牌入驻外推网,定制天中依脉品牌推广信息,可以显著提高天中依脉产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

天中依脉怎么样

公司简介:

天中依脉集团成立于2009年,现拥有三家全资子公司:天津市天中依脉科技开发有限公司、依脉人工智能医疗科技(天津)有限公司和汇汉依脉智能科技(上海)有限公司。公司坐落于天津滨海高新区华苑产业区,是我国专注于中医四诊客观化技术研究和中医诊疗设备的研发与制造的科技型国内知名高新企业之一。公司具有国内一流的中医诊疗仪器研发团队,完善的生产体系和检验设备,产品质量稳定可靠。公司的脉象仪,舌象仪等产品获得国家中医药管理局中医诊疗设备2011版第一批推荐品目。

天中依脉是较早专注于中医诊疗客观化的高新技术企业,核心技术脱胎于天津中医药大学、天津大学历届专家及从上世纪80年代开始的“中医客观化技术”研究。依脉人工智能医疗科技(天津)有限公司是天中依脉的全资子公司,致力于发展“中医云脑”智能化云中医服务,参与国家“一带一路”中医文化传播与技术推广,全面支持国家医联体建设、家庭医生签约服务等领域的中医药服务,践行健康中国战略。

 15625675637646365997938.png

2009年创立至今,天中依脉与国内三十余家高校及高级医疗机构建立了长期深入的科研合作关系,拥有200多项国家专利及软件著作等知识产权,产品服务于500余家医疗机构,成为中医智能行业的领航者。

公司荣誉:

●2009年,参与国家中医诊断仪器国际以及国家行业标准制定

●2009年,参与火星MARS500计划项目

●2011年,参与承担国家973项目

●2011年,舌象仪和脉象仪同时入选国家中医药管理局《中医诊疗设备推荐品目2011版第一批》

●2012年,参与国家自然基金项目

●2012年,参与国家十二五支撑项目

●2013年,获得中国科技部“科技型中小企业技术创新基金”

●2018年,天中依脉“智云中医”中医医联体管理、服务体系上市,并与全国多家中医机构建立合作关系。

公司愿景:

1、中医客观化诊疗技术,中医健康大数据和人工智能科技的国际领导品牌!

2、建立开放、共享、共赢的中医健康数据服务平台,打造中医健康产业生态群。

3、推动先进的中医科技和传统文化走向世界,服务全人类健康!

公司使命:

创新中医科技,传承中医文化,引领健康生活!

Company profile: Tianzhong Yimai group, founded in 2009, now has three wholly-owned subsidiaries: Tianjin Tianzhong Yimai Technology Development Co., Ltd., Yimai artificial intelligence medical technology (Tianjin) Co., Ltd. and Huihan Yimai Intelligent Technology (Shanghai) Co., Ltd. The company is located in Huayuan Industrial Zone, Binhai high tech Zone, Tianjin. It is one of the well-known high-tech enterprises in China, which focuses on the research and development and manufacturing of the four diagnosis and treatment objectification technology of traditional Chinese medicine and the diagnosis and treatment equipment of traditional Chinese medicine. The company has a domestic first-class R & D team of TCM diagnosis and treatment instruments, perfect production system and testing equipment, and stable and reliable product quality. The company's pulse instrument, tongue instrument and other products have won the first batch of recommended items of Chinese medicine diagnosis and treatment equipment 2011 edition of the State Administration of traditional Chinese medicine. Tianzhong Yimai is an early high-tech enterprise focusing on the objectification of TCM diagnosis and treatment. Its core technology was born from the experts of Tianjin University of traditional Chinese medicine, Tianjin University and the research on "objectification technology of TCM" since the 1980s. One belt, one road, China's Tianjin medical company (China) is a wholly-owned subsidiary of the Chinese medicine company. It is committed to the development of the "Yun Nao" intelligent Chinese medicine service, participating in the "one belt and one way" Chinese medicine culture dissemination and technology promotion, and fully supporting the traditional Chinese medicine service in the fields of national medical conjoined construction, family doctor's contract service and so on, and practicing the healthy China strategy. Since its establishment in 2009, Tianzhong Yimai has established a long-term and in-depth scientific research cooperation relationship with more than 30 universities and advanced medical institutions in China. It has more than 200 national patents and software works and other intellectual property rights. Its products serve more than 500 medical institutions and become a leader in the intelligent industry of traditional Chinese medicine. Honors of the company: ● in 2009, participated in the development of international and national industry standards for diagnostic instruments of traditional Chinese medicine ● in 2009, participated in Mars Mars 500 program project ● in 2011, participated in the national 973 project ● in 2011, tongue imager and pulse imager were selected into the first batch of recommended items of Chinese medical diagnosis and treatment equipment 2011 edition by the State Administration of traditional Chinese medicine ● in 2012, participated in the national natural fund project ● 201 2 years, participated in the national 12th Five Year Plan support project ● in 2013, won the "technology innovation fund for small and medium-sized enterprises of science and technology type" of the Ministry of science and technology of China ● in 2018, Tianzhong Yimai "Zhiyun TCM" TCM management and service system went public, and established cooperation with many TCM institutions across the country. Company vision: 1. Objective diagnosis and treatment technology of traditional Chinese medicine, international leading brand of health big data and artificial intelligence technology of traditional Chinese medicine! 2. Establish an open, shared and win-win TCM health data service platform, and build an ecosystem of TCM health industry. 3. Promote the advanced technology of traditional Chinese medicine and traditional culture to the world, and serve the health of all mankind! Mission of the company: innovate TCM technology, inherit TCM culture and lead healthy life!

本文链接: https://brand.waitui.com/93449407c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

热门中概股美股盘前普涨,蔚来涨超4%

36氪获悉,热门中概股美股盘前普涨,截至发稿,蔚来涨超4%,百度涨超2%,爱奇艺涨5%,阿里巴巴、拼多多、B站、微博、小鹏汽车涨超1%,京东涨0.8%,理想汽车涨0.36%。

2小时前

中密控股:雅鲁藏布江下游水电工程对公司业绩影响积极但有限

36氪获悉,中密控股在互动平台表示,子公司新地佩尔的阀门和优泰科的橡塑密封已经在水电水利领域有较多的应用业绩,如白鹤滩水电站、乌东德水电站中都有我们的产品。我们一直关注雅鲁藏布江下游水电工程,也会积极参与其中。但此项目周期很长,目前刚刚正式开工建设,对公司产品的需求量以及公司能从中获得多少订单量仍具有不确定性。根据我们的判断,此项目对公司总体业绩的影响积极但有限。

2小时前

大连圣亚:公司股票继续停牌,预计停牌时间不超过3个交易日

36氪获悉,大连圣亚公告,因公司正在筹划向特定对象发行股票事项,若该事项进展顺利,可能导致公司控制权发生变更。截至本公告披露日,相关各方正在积极推进本次交易的各项工作,公司预计无法在2025年7月24日(星期四)上午开市起复牌。经向上海证券交易所申请,公司股票将于2025年7月24日(星期四)上午开市起继续停牌,预计停牌时间不超过3个交易日。

2小时前

摩根大通对特斯拉Robotaxi首秀持审慎乐观态度

特斯拉即将于周三盘后公布第二季度财报,在此之前,摩根大通对其新推出的Robotaxi业务发布了一份谨慎乐观的评估报告。该行分析师在奥斯汀实地体验自动驾驶服务后,评价其表现“稳健”且持续安全——这对于长期看空特斯拉的投行实属罕见认可。特斯拉于6月22日推出该项网络打车服务,目前已在奥斯汀划定42平方英里的运营区域,不过Alphabet旗下Waymo在当地扩张更为迅速。(新浪财经)

2小时前

高争民爆:目前经营情况正常,不存在应披露而未披露的重大事项

36氪获悉,高争民爆公告,公司股票交易价格连续两个交易日收盘价格涨幅偏离值累计超过20%,属于股票交易异常波动情况。经核实,公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信息;近期公司经营情况及内外部经营环境未发生重大变化;公司、控股股东和实际控制人不存在关于本公司的应披露而未披露的重大事项,或处于筹划阶段的重大事项。

2小时前

本页详细列出关于天中依脉的品牌信息,含品牌所属公司介绍,天中依脉所处行业的品牌地位及优势。
咨询